Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Mallinckrodt
Healthtrust
Farmers Insurance
Chinese Patent Office

Generated: September 15, 2019

DrugPatentWatch Database Preview

Patent: 6,664,107

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,664,107
Title: CD45 disrupted nucleic acid
Abstract:A mammal lacking expression of particular CD45 isoform in certain cells of the immune system is provided. The mammal may optionally contain a transgene encoding the CD45RO isoform. Also provided are methods of using these mammals.
Inventor(s): Mak; Tak Wah (Toronto, CA), Kishihara; Kenji (Fukuoka, JP)
Assignee: Ontario Cancer Institute, University Health Network (Toronto, CA)
Application Number:08/191,225
Patent Claims:see list of patent claims

Details for Patent 6,664,107

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Ontario Cancer Institute, University Health Network (Toronto, CA) 2020-12-16 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Ontario Cancer Institute, University Health Network (Toronto, CA) 2020-12-16 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Ontario Cancer Institute, University Health Network (Toronto, CA) 2020-12-16 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Federal Trade Commission
Queensland Health
McKesson
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.